Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets
Introduction
Vascular diseases are the number one public health issue in the developed world resulting in devastating symptoms relating to coronary artery occlusion, peripheral vascular insufficiency and cerebrovascular disorders. These diseases develop in millions of people annually, resulting in major morbidity and mortality. In these disease states, organ infarction is mediated by arterial thrombosis and is associated with vascular inflammation. Platelets and the endothelium have been recognized for decades as key pathological components of these processes [1].
In more recent years, extracellular nucleotides have become clearly recognized for the important role that they play in modulating a variety of processes linked to vascular inflammation and thrombosis [2]. In general, extracellular nucleotides tend to induce inflammation, whereas nucleosides largely result in cellular events that downregulate such activation responses. Selective pharmacological agents and experiments studying mutant mice bolster these observations. Clinical modalities to interfere with platelet-mediated arterial thrombosis have included successful strategies that target platelet receptors for extracellular nucleotides (e.g. inhibition of the platelet ADP receptor P2Y12 by the antithrombotic drug clopidogrel) [3], [4], [5].
Section snippets
Nucleosides and nucleotides as signaling molecules
Nucleosides are glycosylamines made by attaching a nucleobase (purine or pyrimidine) to a pentose sugar ring. Examples of these include cytidine, uridine, adenosine, guanosine, thymidine and inosine. Nucleosides are phosphorylated by specific kinases in the cell, producing nucleotides. Typically, nucleotides are considered the monomeric, structural unit of nucleotide chains that form nucleic acids (RNA and DNA). Nucleotides also play important roles in cellular energy transport and
Vascular ecto-nucleotidases
Nucleotide-mediated effects within the vasculature are modulated by ecto-enzymes termed ecto-nucleotidases that bind and hydrolyze extracellular nucleotides, in certain circumstances ultimately to the respective nucleosides. These proteins are structurally distinct from intracellular nucleotidases, alkaline phosphatases and ecto-5′-nucleotidase; the latter are enzymes capable of releasing phosphate from a large variety of organic compounds, in addition to the hydrolysis of nucleotides [21].
The
CD39/ecto-nucleoside triphosphate diphosphohydrolase (E-NTPDase family)
CD39 was originally characterized as an activation marker, identified on B cells, monocytes, subsets of activated NK-cells and T-lymphocytes, and weakly on platelets [31], [32], [33]. Once the biochemical function of CD39 was elucidated, work rapidly proceeded on genes that share considerable sequence homology, including the five apyrase conserved regions [37], [38]. The NTPDase family of enzymes has grown to include eight enzymes. Some of these enzymes are membrane-attached with extracellular
CD39/NTPDase, platelets and thrombus formation
Platelet activation and integrin ligation in response to multiple agonists are known to be dependent upon the release of extracellular nucleotides and therefore regulated by specific antagonists of the P2Y1, P2Y12 and P2X1 receptors [47], [54], [55]. In vivo, activated platelets appear to contribute to thrombin generation through the exposure of phosphatidylserine, forming a procoagulant catalytic surface, and through platelet–leukocyte–microparticle interactions that result in exposure of
NTPDase and disordered thromboregulation
Vascular inflammation and thrombosis are considered underlying factors in many common clinical disorders, including atherosclerosis, post-angioplasty injury [59], [60]) and are also very relevant in transplantation reactions (as reviewed in [61]). Forms of ischemia–reperfusion, an obligate component of transplantation, result in acute inflammatory responses, characterized by platelet microthrombi, “plugging” of circulating blood cells in capillaries or hepatic sinusoids, with concomitant
Therapeutic potential of NTPDases
Induced upregulation of CD39/NTPDase1 has major potential beneficial effects on the platelet and endothelial cell activation that may be observed in the setting of vascular inflammation. In the light of differential functional and expression data, we have proposed opposing functions in hemostasis and thromboregulation for CD39/NTPDase1 and CD39L1/NTPDase2 within the vasculature [2], [41].
These altered patterns of platelet and vascular activation may indicate the substantive potential of
Conclusions
This review has attempted to summarize those components of purinergic signaling as pertaining to vascular injury and inflammation that are modulated by the CD39/NTPDase family of ecto-nucleotidases. Nucleotide-mediated mechanisms might dictate processes of vascular injury, platelet activation, thromboregulatory disturbances and consequently vascular remodeling. We have suggested that modulated, distinctive CD39/NTPDase-1 and CD39L1/NTPDase-2 expression (by endothelium, leukocytes and platelets
Acknowledgment
National Institutes of Health for grant support.
References (79)
- et al.
Cellular distribution and functions of P2 receptor subtypes in different systems
Int. Rev. Cytol.
(2004) - et al.
Purinoceptors—Are there families of P2X and P2Y purinoceptors
Pharmacol. Ther.
(1994) - et al.
Emerging roles of purinergic signaling in gastrointestinal epithelial secretion and hepatobiliary function
Gastroenterology
(1999) - et al.
Adenosine receptors
Neuropharmacology
(1995) Ecto-ATPases: identities and functions
Int. Rev. Cytol.
(1995)- et al.
The recently deorphanized GPR80 (GPR99) proposed to be the P2Y15 receptor is not a genuine P2Y receptor
Trends Pharmacol. Sci.
(2005) - et al.
Release, metabolism and interconversion of adenine and uridine nucleotides: implications for G protein-coupled P2 receptor agonist selectivity
Trends Pharmacol. Sci.
(1997) Two novel families of ectonucleotidases: molecular structure, catalytic properties and a search for function
TIPS
(1999)- et al.
Desensitization of angiotensin receptor function
Kidney Int.
(1994) - et al.
Human CD38: a glycoprotein in search of a function
Immunol. Today
(1994)
Identification and characterization of CD39 vascular ATP diphosphohydrolase
J. Biol. Chem.
CD39 is an ecto-(Ca2+, Mg2+)-apyrase
J. Biol. Chem.
Purification and cloning of a soluble ATP-diphosphohydrolase (apyrase) from potato tubers (solanum tuberosum)
Biochem. Biophys. Res. Commun.
Golgi localization and functional expression of human uridine diphosphatase
J. Biol. Chem.
Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation
Blood
Palmitoylation targets CD39/endothelial ATP diphosphohydrolase to caveolae
J. Biol. Chem.
Receptors, rafts, and microvesicles in thrombosis and inflammation
J. Thromb. Haemost.
Cholesterol-dependent lipid assemblies regulate the activity of the ecto-nucleotidase CD39
J. Biol. Chem.
Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation
Blood
Hypoxia and modification of the endothelium—Implications for regulation of vascular homeostatic properties
Semin. Cell Biol.
Delayed xenograft rejection
Immunol. Today
Xenotransplantation—Recent progress and current perspectives
Curr. Opin. Immunol.
Xenotransplantation
Adv. Immunol.
The pathogenesis of atherosclerosis—An update
N. Engl. J. Med.
Modulation of extracellular nucleotide-mediated signaling by CD39/nucleoside triphosphate diphosphohydrolase-1
Drug Dev. Res.
The antiplatelet effects of ticlopidine and clopidogrel
Ann. Intern. Med.
Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis
Semin. Thromb. Hemost.
Comparative benefits of clopidogrel and aspirin in high-risk patient populations: lessons from the CAPRIE and CURE studies
Arch. Intern. Med.
The physiological activity of adenine compounds with special reference to their action upon the mammalian heart
J. Physiol. (London)
Purinergic nerves
Pharmacol. Rev.
Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides
Am. J. Physiol.
Origin, metabolism and function of extracellular adenine nucleotides in the blood [published erratum appears in Klin Wochenschr 1989 May 67 (10) (15) 558]
Klin. Wochenschr.
Nomenclature and classification of purinoreceptors
Pharmacol. Rev.
P2X receptors—An emerging channel family
Eur. J. Neurosci.
Disordered regulation of coagulation and platelet activation in xenotransplantation
Xenotransplantation
P2Y nucleotide receptors in the immune system: signaling by a P2Y(2) receptor in U937 monocytes
Drug Dev. Res.
Ecto-enzymes of lymphoid cells
Immunol. Rev.
Nomenclature for two families of novel ectonucleotidases
Molecular and functional properties of E-NTPDase-1, E-NTPDase-2 and 5′-ectonucleotidase
Cited by (133)
Adenosine metabolism in the vascular system
2021, Biochemical PharmacologyImplications of CD39 in immune-related diseases
2020, International ImmunopharmacologyLambda-cyhalothrin exposure alters purine nucleotide hydrolysis and nucleotidase gene expression pattern in platelets and liver of rats
2019, Chemico-Biological Interactions